In contrast, Basal and Her2 showed a higher expression compared to LumB, but not Lum A, which suggests an increased expression of Fbln2 in tumor cells, particularly with EMT, myoepithelial turnover, and tumor invasion [64–66]. This evidence concerns the gene ERBB2 and neoplasm.